Whitman Walker Health CRS

Location	1701 14th Street, N.W. Washington D.C., 20009 United States of America
Phone	202-939-7661
CRS Coordinator	Anna Wimpelberg awimpelberg@whitman-walker.org 202-797-3589
CRS Leader	Sarah Henn shenn@whitman-walker.org 202-745-6172
Studies	A5128: US Genomic Sampling A5321: Decay of HIV-1 Reservoirs in Participants on Long-Term Antiretroviral Therapy: The ACTG HIV Reservoirs Cohort (AHRC) Study A5345: HIV Rebound & Control Biomarkers A5354: Early ART in Acute HIV A5366: Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation with Histone Deacetylase Inhibitors A5360: MINMON Study-Monitoring SOF/VEL in Treatment Naïve, Chronic HCV Participants A5380: Glecaprevir/pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection (PURGE-C) A5332: REPRIEVE Trial A5324: A Randomized, Double-Blinded, Placebo-Controlled Trial Comparing Antiretroviral Intensification with Maraviroc and Dolutegravir with No Intensification or Intensification with Dolutegravir Alone for the Treatment of Cognitive Impairment in HIV